Helptag Broadcast Approval - Approved

Mar 15, 2010

You have approved this broadcast.
Thank you! You may still leave comments.
Latest in Home
Radiation Symbol
CT 5-star quality rating system supports optimization
August 7, 2026
Stoker222
Jaap Stoker: AI can assist reviewers, but novelty remains human
August 6, 2026
Representative amyloid PET images acquired with flutemetamol, florbetaben, and florbetapir across a range of Centiloid values.
Amyloid PET scores vary with reference-region choice, Spanish study finds
August 5, 2026
Fatigue is one of the most common and debilitating symptoms of Long COVID.
Multi-organ MRI shows no added benefit in major UK Long COVID trial
August 4, 2026
More in Home
CT 5-star quality rating system supports optimization
By Will Morton
The rating framework demonstrated robust reproducibility, with three-reader concordance reaching up to 93% in highly standardized centers.
August 7, 2026
Radiation Symbol
Jaap Stoker: AI can assist reviewers, but novelty remains human
By Claudia Tschabuschnig
Incoming European Radiology Experimental Editor-in-Chief Prof. Jaap Stoker gives insights into his new role and the future of scientific publishing.
August 6, 2026
Stoker222
Amyloid PET scores vary with reference-region choice, Spanish study finds
By Claudia Tschabuschnig
A Spanish study found that the brain region used as a reference can substantially alter Centiloid scores, while whole-cerebellum normalization produced the most consistent results.
August 5, 2026
Representative amyloid PET images acquired with flutemetamol, florbetaben, and florbetapir across a range of Centiloid values.
Multi-organ MRI shows no added benefit in major UK Long COVID trial
By Claudia Tschabuschnig
A major UK trial found no benefit from routinely adding multi-organ MRI to specialist Long COVID care. Abnormalities were detected, but fatigue and quality of life did not improve.
August 4, 2026
Fatigue is one of the most common and debilitating symptoms of Long COVID.
Europe’s lung screening training gaps sharpen focus on implementation
By Claudia Tschabuschnig
A new SOLACE survey reveals wide variation in lung cancer screening training across Europe, underscoring the need for harmonized standards and coordinated care pathways.
August 3, 2026
Lung Cancer Stages 400
EBR accepts registrations for EDiR, launches EDiR Academy
By AuntMinnieEurope.com staff writers
July 31, 2026
Doctors Residents Student Education 400
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
By Claudia Tschabuschnig
A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.
July 30, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
Scottish team designs 10-year sustainability model for preclinical imaging
By Claudia Tschabuschnig
A Scottish team has designed a theoretical 10-year strategy for keeping a multimodal preclinical imaging facility financially viable, operationally resilient, environmentally responsible, and accessible to researchers.
July 29, 2026
Pexels Thirdman 8940356 (1)
ESMI review maps cancer biology ahead of TOPIM 2026
By Claudia Tschabuschnig
Ahead of TOPIM 2026, a new Nature Reviews Cancer article explores how molecular imaging can reveal the biological processes driving tumor growth, resistance, and immune evasion.
July 28, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
Behind the Editors' desk: How AI Is reshaping scientific publishing
By Claudia Tschabuschnig
From peer review to paper mills, the Editors' Forum explored how AI is transforming scientific publishing.
July 27, 2026
Forum
Societies host events for MR Safety Week
By AuntMinnie.com staff writers
Observances trace to the 2001 death of Michael Colombini.
July 27, 2026
Safety
SPECT/CT viable over PET/CT for high-risk prostate cancer staging
By Will Morton
Considering its broader accessibility, Tc-99m MIP-1404 CZT SPECT/CT may represent a practical alternative for primary staging.
July 24, 2026
Maximum intensity projection of Ga-68 PSMA-11 PET/CE-CT (A), Tc-99m MIP-1404 CZT SPECT/CT (B) and Tc-99m HDP CZT SPECT/CT (C) imaging. Ga-68 PSMA-11 PET/CE-CT and Tc-99m MIP-1404 CZT SPECT/CT showing tracer uptake in lymph nodes below the iliac bifurcation and above, paraaortic and left supraclavicular, bone uptake in the right proximal femur and right scapula (arrows). Tc-99m HDP CZT SPECT/CT did not show any uptake suspicious for metastatic disease. No sclerotic lesions suspicious of metastases were detected by the CT component in any of the studies. Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (D) and Tc-99m MIP-1404 CZT SPECT/CT (E) showing uptake in lymph nodes in the left pelvic area below the iliac bifurcation (arrows). Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (F) and Tc-99m MIP-1404 CZT SPECT/CT (G) showing uptake in the right proximal femur, not detected by Tc-99m HDP CZT SPECT/CT (H), (arrows).
Page 1 of 89
Next Page